Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sorrento

Expert issues report on how to settle highly contentious New Orleans church bankruptcy case

Mohsin ‘Mo’ Meghji was paid $350,000 to advise on conflicting settlement proposals from the church and clergy abuse victims

The Guardian - US

Expert hired to help resolve New Orleans archdiocese bankruptcy faces FBI scrutiny

Mohsin Meghji’s conduct in a separate case raised ethics questions as ex-judge he was linked to faces investigation

The Guardian - US

New Orleans archdiocese bankruptcy parties wary of turnaround expert after WSJ investigation

Mohsin Meghji drew scrutiny for behavior with bankruptcy judges in unrelated case involving drugmaker

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Super Bowl lesson: Starting on defense can give you an advantage

In this informative article, we explore the lessons learned from the overtime coin toss in Super Bowl LVIII and how they can be applied in negotiations and...

Top News

Royal Caribbean leans into 2 huge food-and-beverage trends

The cruise line has embraced a key bar trend and something that's becoming more popular on the Las Vegas Strip.

The Street

Royal Caribbean cruise line cancels unpopular dining change

The cruise line's passengers got angry at the suggestion that it was going to take away something very popular.

The Street

David Goodwillie vows to ‘speak my truth’ after third club cancel contract following fans backlash

Australian second-tier side FC Sorrento announced on Wednesday that they had recruited the 34-year-old.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

David Goodwillie vows to ‘speak my truth’ after another club cancels his deal

Australian second-tier side FC Sorrento announced on Wednesday that they had recruited the 34-year-old.

The Independent UK

David Goodwillie has contract cancelled in Australia after backlash

The 34-year-old was ruled by a judge at a civil court case in 2017 to have raped a woman in 2011.

The Independent UK

Australian club pull plug on David Goodwillie signing hours after announcement

Australian club Sorrento FC have rescinded a contract offered to David Goodwillie hours after announcing he had been signed.

The National (Scotland)

B&M launches huge Easter sale with up to £100 off select garden furniture

Shoppers can bag a deal just in time for the turn of the warmer weather, but they'll have to be quick!

Chronicle Live

Royal Caribbean vs. Celebrity: Which Cruise Line Is Better?

The cruise lines have the same ownership, but there are some major differences.

The Street

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck's (NYSE:MRK) lead asset MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease (ESRD). Merck shares traded in a range of $89.72 to $90.97 on day volume of 5.2…

Benzinga

FDA Gives Green Signal To Human Trial For Sorrento's STI-9167 Against Omicron

The FDA has cleared Sorrento Therapeutics Inc's (NASDAQ:SRNE) investigational new drug application (IND) for intravenous (IV) STI-9167 (COVISHIELD) to study the safety and pharmacokinetics in healthy volunteers. STI-9167 is the IV formulation of the intranasal STI-9199 neutralizing antibody. Also Read: Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients. The Phase 1 study…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients

The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ:SRNE) Phase 3 trial of abivertinib in severe COVID-19 patients. The clinical trial will be conducted in 2 phases, and the initial run-in will define the recommended Phase 3 Dose. In October last year, Sorrento released preliminary results of two phase 2 studies that seemed to show…

Benzinga

Sorrento's Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants

Sorrento Therapeutics Inc (NASDAQ:SRNE) announced the publication of a preprint entitled "Chimeric mRNA based COVID-19 vaccine induces protective immunity against Omicron and Delta." Serum collected from omicron-specific mRNA vaccine immunized animals provided superior protection against the infection of omicron strain, including the BA.1, BA.1+R346K, and the more recent BA.2 sublineage. The data demonstrated…

Benzinga

The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Sorrento Therapeutics' COVID-19 Antibody Works Against Omicron Variant

Sorrento Therapeutics Inc (NASDAQ: SRNE) has

Get all your
news in one place.

100’s of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.